AzTrials
AzTrials

AcupunctureEarly Phase 1NCT02553005

Evaluation of the Effect of Acupuncture on Hand Pain, Functional Deficits and Health Related Quality of Life in Patients With Rheumatoid Arthritis

A Early Phase 1 study testing Acupuncture in people with Acupuncture, run by University of Coimbra at 1 site in Portugal.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Rheumatoid Arthritis (RA) is a systemic inflammatory disease characterized by functional disability and pain. Although acupuncture is widely used, western acupuncture studies on RA show no conclusive positive result. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Acupuncture
What is being tested?
Acupuncture
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
90 participants
Where
1 sitePortugal
Study dates
May 2015to Jun 2017
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Compliance inform consent
  • Patients with RA
  • Fulfill The ACR criteria of RA
  • Impairment of the hand strength with or without pain in the hands during the grip procedure
  • Chronic pain: either persistent or intermittent over a minimum period of three months prior to recruitment
  • Current pain: greater than 30/ 100 mm on a pain visual analogue scale (VAS) within the last 24 hours despite medication
  • Patients on stable dose treatment for at least 3 weeks

Who cannot join

  • Under the age of 18 years
  • Previously had acupuncture
  • Localized skin infections
  • Severe chronic or uncontrolled co-morbid disease
  • The wish to get a pension.

Trial locations and contacts

1 site in 1 country.

Susana Seca, MSc contact

+351914265319

susana.seca@hotmail.com

Portugal1 site, 1 recruiting
  • Faculty of Medicine - University of Coimbra

    Coimbra, Coimbra District, 3045

    Susana Seca, MSc, +351914265319, susana.seca@hotmail.com

    Recruiting

Other trials in Portugal

About this study

Official title: Evaluation of the Effect of Acupuncture on Hand Pain, Functional Deficits and Health Related Quality of Life in Patients With Rheumatoid Arthritis - A Multicenter, Double-blinded, Randomised Clinical Trial

Rheumatoid Arthritis (RA) is a systemic inflammatory disease characterized by functional disability and pain. Although acupuncture is widely used, western acupuncture studies on RA show no conclusive positive result. Acupuncture is regarded as a reflex therapy, and Traditional Chinese Medicine (TCM) diagnosis was shown to be an individual neurovegetative state allowing to individually allocated acupoints. Positive results were reported using a classical diagnostic procedure to allocate acupoints to the patient according to the Shang Han Lun. The investigators are interested if acupuncture compatible with this ancient theory would be successful in improve hand function in RA patients.

The investigators therefore developed a prospective randomized control trial in a three-armed parallel group design with a standardized treatment intervention. Only patients with the TCM diagnosis of a so-called Turning Point syndrome will be allowed in the experimental phase. This may harmonize TCM diagnosis and the standardized intervention, in order to optimize potential therapeutic effects.

Read the detailed description

The study design is divided into two parts. First the investigators will follow a non-experimental nature design. Based on the results of this exploratory study we will then start a three-armed parallel-group study with equal randomization (1:1:1), prospective, double-blind, placebo-controlled and multicenter that will be conducted in Portugal (2 sites).

We plan to include 381 patients with RA of the hands in accordance to the selection criteria. The patients are going to be recruited from the national centers of rheumatology and patient associations in the time from May 2015 to October 2016. All patients are supposed to sign an informed consent at the time of enrollment according to the rules of the Helsinki Declaration.

Task 1 In the first task we are going to develop a non-experimental, exploratory and descriptive nature design with the goal to describe the epidemiological, clinical and genetic profile of patients with RA of the hands according to their TCM diagnosis.

We will use an individual instrument for the collection of data to characterize the patients socio-demographically and clinically.

The main characteristics, complaints and objective examinations of participants, will be characterized by a qualified and experienced acupuncturist (first physician), in accordance to the Heidelberg Model (HM) to TCM. This physician will assess the pain in the hand by using a pressure algometer in two different distinct points. It is well known that the lower the ability to tolerate the pressure is, the worse will be the individual pain. The same researcher will also record clinical features based on data from tongue-diagnosis that will have been conducted before by an Automatic Tongue Diagnosis System (ATDS). The results so far demonstrate that the ATDS is very consistent even in settings with different environmental lighting.

The correlation between pattern classification in TCM and biomarkers that are expressed in genetic profiles in RA patients will be explored similarly to other recent studies whose results indicated that different patterns could be regarded as a consequence of biological networks with deviant gene expressions in various affected tissues and immune effector cells.

Due to financial limitations, we will only select 15 participants randomly from each of the different TCM patterns found. Eight ml of venous blood will be collected in anticoagulation tubes from each participant and will then be tested in a microarray assay by using the Trizol extraction method.

Task 2 Next, we aim to evaluate the effect of acupuncture on pain and strength of the hand according to the criteria of the HM to TCM for a specific vegetative functional state called the TP syndrome.

A sample of 90 patients with clinical features of a TP syndrome will be assigned randomly to one of three parallel groups, in a 1:1:1 ratio to either the control, verum or sham group with the help of a computer-generated randomization programme.

The first physician will mark the points with a red or blue colour on the patients that have been randomized to the verum intervention group as well as on the patients that have been assigned to the sham intervention group.

Afterwards, the first physician will present these data to a study-coordination program that will assign the colour-codes to a sequence of possible treatment modalities by using a computer-generated randomization table. A second physician will then be informed by the programme about the colour of the points that is supposed to be needled. The second physician will then perform a respective standardized needling technique to the selected points indicated by the colour which corresponds to either the sham or verum points.

We decided to use the Leopard Spot technique, a blood-letting acupuncture therapy that uses sterile subcutaneous needles (0,30mmx8mm) and it is known to increase local microcirculation by inducing a vegetative response. All patients will receive three sessions of treatment. After the acupuncture session, the patients must dress with light garment to cover any potential marks from needling.

Before and after the treatments, the patients will return to the first physician for the assessment of the outcomes. The first physician will not know which acupuncture points have been used.

The participants will be followed up for six times Assessment (0) will take place after randomization; assessments (1), (3) and (5) will take place five minutes after the intervention; assessment (2) will be done 24 hours after the first intervention and assessment (4) three days after the first intervention.

The assessments include an evaluation of the patients tolerance to pain in the hand by using a pressure algometer; a measurement of their grip strength with the help of a dynamometer and an evaluation of the nerve conduction and muscle function in the hand using an electromyography.

Task 3 In this task we intend to do a longitudinal study to assess the effect of the acupuncture treatment on inflammation and on the quality of life.

The patients that had been randomized to groups 2 and 3 will be treated two times per week, over a period of three weeks, respecting an interval of 72 hours in between treatments. Therefore these participants will be followed up in the assessments (6), (8), (10), (12), (14) and (16) - (before intervention) and assessments (7), (5), (9), (11), (13), (15) and (17) - (five minutes after intervention) (Appendix 6). The assessments (0), (5) and (18) will also include another parameter to measure the inflammation condition: the cortisol and interleukins level in the saliva.

All the patients randomized to groups 1, 2 and 3 will be followed up in the assessments (0) and (18) - 28 days after assessment (0), also to measure of pain by Visual Analogue Scale and of quality of life by Health Survey SF-36.

The results of the first task will be conducted by analyzing statistical data, using techniques of descriptive statistics and nonparametric tests. To the second and third tasks the results will be analyzed by Pearson Correlation Coefficients and a Multivariate Analysis of Variance with the significance set at p<0,05.

Conditions
Acupuncture
Being tested
Acupuncture
Keywords
Acupuncture, Rheumatoid Arthritis, Quality of life, Hand Strength
Medical subject headings
Arthritis, Rheumatoid

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02553005
Study groupRoleWhat they receive
sham acupunctureSham comparatorFalse acupuncture treatment using not acupuncture points
Receives: Procedure: Acupuncture
verum acupunctureExperimentalReal acupuncture treatment
Receives: Procedure: Acupuncture
ControlNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. gene expression profiles (Assessment by microarray)

    Assessment by microarray

    Measured: up to 19 months

  2. Quality of life (Assessment by SF-36 scale)

    Assessment by SF-36 scale

    Measured: up to 19 months

Secondary outcomes (4)
  1. Cortisol levels in blood

    Assessment by cortisol levels in blood

    Measured: up to 12 months

  2. Interleucines levels in blood

    Assessment by interleucines levels in blood

    Measured: up to 12 months

  3. hand pain (Assessment by algometry)

    Assessment by algometry

    Measured: up to 19 months

  4. hand strength (Assessment by dynamometry)

    Assessment by dynamometry

    Measured: up to 19 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2015 (estimated)
  2. Study startMay 2015
  3. Primary completionOct 2015 (estimated)
  4. Study completionJun 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02553005
Sponsor's protocol ID
University of Coimbra
Status last verified
Sep 2015
First submitted
12 Sep 2015
Last updated
29 Sep 2015
Results posted
No
Data monitoring committee
No

Publications

  • Seca S, Kirch S, Cabrita AS, Greten HJ. Evaluation of the effect of acupuncture on hand pain, functional deficits and health-related quality of life in patients with rheumatoid arthritis--A study protocol for a multicenter, double-blind, randomized clinical trial. J Integr Med. 2016 May;14(3):219-27. doi: 10.1016/S2095-4964(16)60254-6.

    PubMed 27181129

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Acupuncture in people with Acupuncture, run by University of Coimbra at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Sep 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Susana Seca, MSc (+351914265319, susana.seca@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

gene expression profiles (Assessment by microarray) (time frame: up to 19 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02553005, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in